Suchergebnisse - "Terabe, Masaki"

PubPharm (192)

1

Preface : NKT Cells for Tumor Immunotherapy

enthalten in: Critical reviews in oncogenesis | 2024

von Terabe, M. | Kumar, V.

2

Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancer

enthalten in: The Journal of clinical investigation | 2023

von Nishio, K. | Pasquet, L. | Camara, K. | +14

3

Compositions and methods for the treatment of HER2-expressing solid tumors

enthalten in: Europäisches Patentamt | 2023

von WOOD LAUREN V | ROBERSON BRENDA D | BERZOFSKY JAY A | +4

4

MAIT cells and MR1 play an immunosuppressive role in glioblastoma through the induction of neutrophils and MDSCs

enthalten in: bioRxiv.org | 2023

von Hana, T. | Terabe, M.

5

Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response

enthalten in: Journal for immunotherapy of cancer | 2022

von Stirling, E. | Terabe, M. | Wilson, A. | +7

6

MULTI-EPITOPE TARP PEPTIDE VACCINE AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von WOOD LAUREN V | BERZOFSKY JAY A | ROBERSON BRENDA D | +1

7

Compositions and methods for the treatment of HER2-expressing solid tumors

enthalten in: Europäisches Patentamt | 2022

von WOOD LAUREN V | ROBERSON BRENDA D | BERZOFSKY JAY A | +4

8

Rethinking immunotherapy in meningiomas

enthalten in: Neuro-oncology | 2021

von Terabe, M. | Wu, J.

CommentOn: Neuro Oncol. 2021 Nov 2;23(11):1922-1935. - PMID 33914067

9

The Role of NKT Cells in Glioblastoma

enthalten in: Cells | 2021

von Brettschneider, E. | Terabe, M.

10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS

enthalten in: Europäisches Patentamt | 2021

von WOOD LAUREN V | ROBERSON BRENDA D | BERZOFSKY JAY A | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]